Loading... Please wait...
About Us
Contact Us
Privacy Policy
Sign in
or
Create an account
My Account
View Cart
Checkout
Search
Home
Report Subject
Medical Affairs
Browse by
Biosimilar Index
Dossier
FirstView
FirstView NPS+
FirstWord Pharma
Therapy Trends
Therapy Trends Updates
Latest Reports
Therapy Area Reports
Report Subject
Emerging Markets
Generics/Biosimilars
Market Access
Medical Affairs
Pharma Marketing
Pharma Sales
Technology/Digital Health
Orphan Drugs
Sort by:
Featured Items
Newest Items
Bestselling
Alphabetical: A to Z
Alphabetical: Z to A
FirstWord Medical Affairs Reports
Next »
Pages:
1
2
3
Learn More
AI in Medical Diagnostics
Evaluating the potential of artificial intelligence to revolutionise and expand medical diagnostics Artificial intelligence (AI) driven technologies have already radically changed practice and outcomes in medical...
Compare
Learn More
Health Insurance Disruptors: Going Digital
Health insurance: how to thrive in an increasingly digital health world Health insurers are being challenged to develop a portfolio of digital services with limited knowledge of their effectiveness and at a considerable...
Compare
Learn More
Pricing Transparency in Pharma
Pharma challenged to engage and shape the drug pricing transparency debate Anxieties about rising drug prices is fuelling an ever louder global demand for price transparency—and reformers are getting their message...
Compare
Learn More
Regulating Digital Health
As digital health progressively enters mainstream therapy, how should it be regulated and to what outcome? Digital health is booming and as investment in digital health technology grows more products and services will...
Compare
Learn More
The Future of Disease Interception
What does pharma need to do to develop this radical health model of the future? Disease interception is a novel healthcare model that identifies, treats and sometimes cures disease before it is fully manifested. There...
Compare
Learn More
The Future of Personalised Medicine: The Role of Simulation and Digital Twins
Beyond the hype, where might simulation and digital twin technology deliver value for pharma? There is considerable excitement about the potential for simulation and digital twin technology to drive the personalised...
Compare
Learn More
The Future of Virtual Healthcare
What strategy should pharma be pursuing in virtual healthcare? Applications for virtual healthcare engagement are quickly evolving beyond websites and apps towards advanced tools such as virtual assistants and virtual...
Compare
Learn More
The Impact of 5G on Healthcare
Health insurance: how to thrive in an increasingly digital health world 5G wireless network technology has the potential to revolutionize pharma's business. Combined with advances in artificial intelligence and machine...
Compare
Learn More
Financing High-Cost Therapies through Reinsurance
Could reinsurance allay health insurers' fear about high cell and gene therapy costs? With the prospect of many cell and gene therapies coming to market in the medium term, often with record breaking list prices and...
Compare
Learn More
The Impact of Drug Compounding on Pharma
Drug compounding meets unmet clinical needs, widens therapy choice and expands patient access to medicines. What are the lessons and opportunities for pharma? Drug compounding is a fast growing sector meeting the needs...
Compare
Learn More
The Future of CRISPR
Where will CRISPR deliver real value? Investors and pharma are enthusiastic about CRISPR gene editing technology: not only can it be used to develop new therapeutics, it has become a powerful tool in drug discovery,...
Compare
Learn More
Virtual Clinical Trials: The future of drug development?
How viable are virtual clinical trials as a model for conducting clinical research? With our deepening understanding of disease and ever more targeted therapies, slow and costly traditional clinical trials alone are no...
Compare
Learn More
Medical-grade Wearable Technology: Applications and implications for pharma
Leveraging clinical wearables and digiceuticals to gain competitive advantage From smart wristbands and glasses to tiny sensors in pills, the latest advances in medical-grade technology are unlocking new opportunities...
Compare
Learn More
Artificial Intelligence and Machine Learning: Applications in Pharma
Where can Artificial Intelligence and Machine Learning really drive change in pharma's business? Artificial Intelligence (AI) and Machine Learning (ML) have the potential to unlock new insights and massively improve...
Compare
Learn More
Voice Assistants and Medical Chatbots in Healthcare
Voice activated technology: What are the potential benefits for pharma? The use of voice-controlled assistants (VCAs) such as Apple's Siri and Amazon's Alexa are familiar to many of us in our daily lives. But how might...
Compare
Learn More
Gene Therapy: Commercial Opportunities and Challenges for Pharma
As gene therapies for major diseases accelerate from the development pipeline, how can pharma exploit near-term opportunities and protect its business going forward? As gene therapies for major diseases accelerate from...
Compare
Learn More
Digital Therapeutics: Taking digital health to a new level
The Digital Therapeutics field is exploding: what does pharma need to know - and do - to get on board? Evidence-based and reimbursed digital therapeutics (DTx) are now part of the health delivery landscape. They hold...
Compare
Learn More
Blockchain: Transformational change for Pharma?
Is blockchain really the technology that can revolutionise pharma's business? Rapidly developing Blockchain technology can deliver transparent, secure and reliable data sharing. It also has the prospect of streamlining...
Compare
Learn More
The Impact of Nanomedicine in the Pharma Industry
Can nanomedicines really offer pharma a compelling alternative approach to precision medicines? Delivering accurate diagnosis for clinicians, safer medicines for patients and lower costs through reduced waste and costly...
Compare
Learn More
Medical Affairs in Emerging Markets
How can medical affairs capability be enhanced to unlock the Brazilian, Russian, Indian and Chinese pharma markets? The pharma markets of Brazil, Russia, India and China (BRIC) are becoming increasingly complex with...
Compare
Next »
Pages:
1
2
3
About Us
Contact Us
Privacy Policy
customer.service@firstwordpharma.com
All Contents Copyright © 2019 Doctor's Guide Publishing Limited All Rights Reserved